Table 1 Baseline characteristics
ProGlide | Manta | p | |
|---|---|---|---|
Number of patients | 76 | 75 | |
Age (years) mean ± SD | 80.8 ± 8.3 | 81.2 ± 6.5 | 0.728 |
Female, n (%) | 46 (60.5) | 33 (44.0) | 0.042 |
BMI (kg/m2) | 25.6 ± 4.7 | 25.7 ± 4.3 | 0.900 |
Diabetes, n (%) | 14 (18.4) | 15 (20.0) | 0.805 |
Hypertension, n (%) | 53 (69.7) | 54 (72.0) | 0.760 |
Prior PCI, n (%) | 23 (30.3) | 26 (34.7) | 0.818 |
Prior CABG, n (%) | 10 (13.2) | 7 (9.3) | 0.457 |
Kreatinin (μmol/L) | 97.0 ± 33.9 | 97.3 ± 27.6 | 0.947 |
eGFR (CKD-EPI, mL/min/1.73 m2) | 58.2 ± 19.7 | 59.8 ± 17.4 | 0.604 |
STS/ACC TAVR score (mean ± SD) | 2.9 ± 1.0 | 2.8 ± 1.0 | 0.546 |
Echocardiographic parameters: | |||
LVEF (%) mean ± SD | 54.2 ± 6.5 | 52.0 ± 11.2 | 0.138 |
Mean aortic valve gradient (mmHg) mean ± SD | 53.7 ± 15.6 | 51.4 ± 15.5 | 0.370 |
Aortic valve area (cm2) mean ± SD | 0.7 ± 0.2 | 0.6 ± 0.2 | 0.403 |
Anatomic data, minimal luminal diameter: | |||
Common femoral artery (mm) mean ± SD | 7.8 ± 1.4 | 8.1 ± 1.5 | 0.247 |
External iliac artery (mm) mean ± SD | 8.2 ± 1.3 | 8.1 ± 1.4 | 0.815 |
Calcification ≥ moderate, n (%) | 48 (63.2) | 32 (42.7) | 0.012 |